Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer

Clinical trial NCT05550558 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05550558
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer

Start date: 2022-11-01
Primary completion: 2025-11-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.